NR4A1 and B-cell non-Hodgkin lymphoma: In contrast, the overexpression of NR4A1 in B cell lymphomas was associated with reduced tumor growth and increased rates of tumor cell apoptosis, while the low expression of NR4A1 led to increased tumor growth and poor clinical outcomes [24].